Table 3 Cumulative 1- and 5 year survival and crude and adjusted hazard ratios of entire cohort
Variables | No. of patients, n (%) | 1-year cumulative survival | 5-year cumulative survival | HR (95% CI) | |
|---|---|---|---|---|---|
Crude | Adjusted | ||||
Overall | 30,721 | 84.4% | 41.7% | ||
No IHD or stroke | 25,114 (82) | 85.4% | 43.5% | 1.0 (reference) | 1.0 (reference) |
IHD | 4,276 (14) | 80.5% | 36.1% | 1.25 (1.20-1.31) | 1.05 (1.00-1.10) |
Stroke | 1,331 (4) | 77.6% | 26.5% | 1.57 (1.46-1.69) | 1.20 (1.12-1.30) |
Stratified by age at prostate cancer diagnosis | |||||
< 60 year | |||||
No IHD or stroke | 2,504 | 93.1% | 62.3% | 1.0 (reference) | 1.0 (reference) |
IHD | 173 | 95.2% | 50.1% | 1.19 (0.90-1.57) | 0.97 (0.73-1.29) |
Stroke | 53 | 90.6% | 55.7% | 1.28 (0.82-1.99) | 1.18 (0.74-1.88) |
60-69 year | |||||
No IHD or stroke | 8,202 | 92.3% | 59.4% | 1.0 (reference) | 1.0 (reference) |
IHD | 1,082 | 91.8% | 56.3% | 1.08 (0.96-1.22) | 0.94 (0.84-1.06) |
Stroke | 284 | 89.3% | 44.8% | 1.51 (1.23-1.85) | 1.19 (0.97-1.46) |
≥ 70 year | |||||
No IHD or stroke | 14,408 | 80.3% | 33.2% | 1.0 (reference) | 1.0 (reference) |
IHD | 3,021 | 75.7% | 28.8% | 1.16 (1.10-1.23) | 1.06 (1.00-1.12) |
Stroke | 994 | 73.6% | 20.7% | 1.38 (1.27-1.50) | 1.20 (1.10-1.30) |